Metropolis: “For us to format this post, we’ll need access to this article: https://www.forbes.com/sites/jacobwendler/2024/07/16/this-startup-raised-52-million-to-develop-blood-tests-for-cancer/, as it requires a membership to preview.”
News
This Startup Raised $5.2 Million To Develop Blood Tests For Cancer
Related Posts
All Posts
News
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
News
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its Board
News
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
Predicta Newsletter
Enter your email address to subscribe.
Enter Email Address:
Predicta Biosciences
750 Main Street, Lab 413
Cambridge, MA 02139